Skip to Content
Merck
All Photos(1)

Documents

F7806

Sigma-Aldrich

3-Fluorobenzyl chloride

96%

Synonym(s):

α-Chloro-3-fluorotoluene, 1-Chloromethyl-3-fluorobenzene

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
FC6H4CH2Cl
CAS Number:
456-42-8
Molecular Weight:
144.57
Beilstein:
742265
EC Number:
207-264-8
MDL number:
MFCD00000904
UNSPSC Code:
12352100
PubChem Substance ID:
24894949

Assay

96%

form

liquid

refractive index

n20/D 1.511 (lit.)

density

1.194 g/mL at 25 °C (lit.)

SMILES string

Fc1cccc(CCl)c1

InChI

1S/C7H6ClF/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2

InChI key

XBDXMDVEZLOGMC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Corrosion
GHS05

Signal Word

Danger

Hazard Statements

H314

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

159.8 °F - closed cup

Flash Point(C)

71 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

William L Scott et al.
Journal of combinatorial chemistry, 11(1), 14-33 (2008-12-25)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D(3) is the global rehearsal of prospective reagents and
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 34-43 (2008-12-25)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports
Steffen Bugge et al.
European journal of medicinal chemistry, 94, 175-194 (2015-03-15)
An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This was done by synthesis and EGFR activity measurement of a series of fragment structures and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service